本文对国内溶血药物进行实验研究筛选，证明尿激酶是目前国内用于高血压脑出血血肿溶解的最佳药物，并对药物的浓度、溶血时间、稀释液进行了一系列的研究。将其研究结果用于高血压壳核、丘脑、脑干出血等６８例经ＣＴ定位，钻孔冲洗引流术后，置管注入尿激酶１万ｕ＋５ｍｌ生理盐水于血肿腔３小时后开放引流，每日三次，获得良好的效果，６８例中２１例死亡（死亡率３０．８８％），４７例存活中ＡＤＬ３级以上达６６．７％。 In this paper, the domestic hemolytic drugs were screened experimentally, proving that urokinase is the best drug for hematoma dissolution of hypertensive intracerebral hemorrhage in China. A series of researches have been done on the drug concentration, hemolysis time and diluent. The results of the study were used in 68 cases of hypertension such as putamen, thalamus and brainstem hemorrhage. After CT drilling and drainage, the urokinase 10 000 u + 5ml saline was injected into the hematoma cavity for 3 hours after catheterization. Three times a day, good results were obtained. Of the 68 cases, 21 died (30.88%) and 47 survived ADL3 (66.7%).